FDA Drug Application (202720) for MYCOPHENOLIC ACID by TEVA PHARMS USA

Back to FDA Applications sponsored by TEVA PHARMS USA

Application Number202720
Product Number001
FormTABLET, DELAYED RELEASE;ORAL
Dosage180MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameMYCOPHENOLIC ACID
Active IngredientMYCOPHENOLIC ACID

Active IngredientCount
List of drugs with Active Ingredient MYCOPHENOLIC ACID2


Back to FDA Applications sponsored by TEVA PHARMS USA